Upload Image (Max 20MB per Image)
The Therapeutic Goods Administration (TGA) of Australia has approved Ikaria Lucassin (terlipressin) for the treatment of Hepatorenal Syndrome Type 1 (HRS 1) in patients who are actively being considered for a liver transplant. The ...
Tags: Hepatorenal Syndrome Type 1, HRS, Australia TGA